Login / Signup

Enhanced Directed Evolution in Mammalian Cells Yields a Hyperefficient Pyrrolysyl tRNA for Noncanonical Amino Acid Mutagenesis.

Delilah JewelRachel E KelemenRachel L HuangZeyu ZhuBharathi SundareshKaitlin MalleyQuan PhamConor LoyndZeyi HuangTim van OpijnenAbhishek Chatterjee
Published in: Angewandte Chemie (International ed. in English) (2024)
Heterologous tRNAs used for noncanonical amino acid (ncAA) mutagenesis in mammalian cells typically show poor activity. We recently introduced a virus-assisted directed evolution strategy (VADER) that can enrich improved tRNA mutants from naïve libraries in mammalian cells. However, VADER was limited to processing only a few thousand mutants; the inability to screen a larger sequence space precluded the identification of highly active variants with distal synergistic mutations. Here, we report VADER2.0, which can process significantly larger mutant libraries. It also employs a novel library design, which maintains base-pairing between distant residues in the stem regions, allowing us to pack a higher density of functional mutants within a fixed sequence space. VADER2.0 enabled simultaneous engineering of the entire acceptor stem of M. mazei pyrrolysyl tRNA (tRNA Pyl ), leading to a remarkably improved variant, which facilitates more efficient incorporation of a wider range of ncAAs, and enables facile development of viral vectors and stable cell-lines for ncAA mutagenesis.
Keyphrases
  • amino acid
  • crispr cas
  • wild type
  • sars cov
  • high throughput
  • copy number
  • minimally invasive
  • quantum dots
  • drug delivery
  • highly efficient
  • bioinformatics analysis